Thomas M Gorter1, Erik A M Verschuuren2, Dirk J van Veldhuisen1, Elke S Hoendermis1, Michiel E Erasmus3, Harm J Bogaard4, Anton Vonk Noordegraaf4, Rolf M F Berger5, Joost P van Melle1, Tineke P Willems6. 1. Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. 2. Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. 3. Department of Thoracic Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. 4. Department of Pulmonary Medicine, VU University Medical Center, Amsterdam, Netherlands. 5. Department of Paediatric Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. 6. Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Abstract
OBJECTIVES: Pulmonary arterial hypertension (PAH) is a progressive and often fatal disease characterized by increased pulmonary vascular resistance (PVR) and right ventricular (RV) failure. End-stage PAH is often an indication for a lung transplant (LTX). Our goal was to study ventricular recovery using cardiac magnetic resonance imaging late after LTX. METHODS: We studied 10 patients with PAH who underwent isolated bilateral LTX. RV and left ventricular (LV) volumes, function and mass were measured. In addition, the RV stroke volume/end-systolic ratio (SV/ESV), the LV eccentricity index, the RV/LV volume ratio, the area of the tricuspid valve annulus and the severity of tricuspid regurgitation (TR) were calculated. RESULTS: The median age was 44 [30-54] years and the mean PVR was 1020 ± 435 dynes·s·cm - 5 . Six patients had ≥ moderate TR. After LTX, the RV ejection fraction increased from 32 to 64% ( P < 0.001) and both RV volume (from 118 to 51 ml/m 2 , P < 0.001) and RV mass (from 69 to 33 g/m 2 , P < 0.001) decreased. The mean SV/ESV ratio increased from 0.5 to 1.9 ( P < 0.001) and the LV mass increased from 55 to 61 g/m 2 ( P = 0.005). There was a decrease in both the LV eccentricity index (from 2.8 to 1.1, P < 0.001) and the RV/LV volume ratio (from 2.3 to 0.8, P < 0.001). The area of the tricuspid valve annulus also decreased (from 9.8 to 4.6 cm 2 /m 2 , P < 0.001); no patient had ≥ mild TR post-LTX. CONCLUSIONS: Cardiac magnetic resonance imaging confirms ventricular recovery after isolated bilateral LTX for end-stage PAH.
OBJECTIVES:Pulmonary arterial hypertension (PAH) is a progressive and often fatal disease characterized by increased pulmonary vascular resistance (PVR) and right ventricular (RV) failure. End-stage PAH is often an indication for a lung transplant (LTX). Our goal was to study ventricular recovery using cardiac magnetic resonance imaging late after LTX. METHODS: We studied 10 patients with PAH who underwent isolated bilateral LTX. RV and left ventricular (LV) volumes, function and mass were measured. In addition, the RV stroke volume/end-systolic ratio (SV/ESV), the LV eccentricity index, the RV/LV volume ratio, the area of the tricuspid valve annulus and the severity of tricuspid regurgitation (TR) were calculated. RESULTS: The median age was 44 [30-54] years and the mean PVR was 1020 ± 435 dynes·s·cm - 5 . Six patients had ≥ moderate TR. After LTX, the RV ejection fraction increased from 32 to 64% ( P < 0.001) and both RV volume (from 118 to 51 ml/m 2 , P < 0.001) and RV mass (from 69 to 33 g/m 2 , P < 0.001) decreased. The mean SV/ESV ratio increased from 0.5 to 1.9 ( P < 0.001) and the LV mass increased from 55 to 61 g/m 2 ( P = 0.005). There was a decrease in both the LV eccentricity index (from 2.8 to 1.1, P < 0.001) and the RV/LV volume ratio (from 2.3 to 0.8, P < 0.001). The area of the tricuspid valve annulus also decreased (from 9.8 to 4.6 cm 2 /m 2 , P < 0.001); no patient had ≥ mild TR post-LTX. CONCLUSIONS: Cardiac magnetic resonance imaging confirms ventricular recovery after isolated bilateral LTX for end-stage PAH.
Authors: Aida Venado; Charles McCulloch; John R Greenland; Patricia Katz; Allison Soong; Pavan Shrestha; Steven Hays; Jeffrey Golden; Rupal Shah; Lorriana E Leard; Mary Ellen Kleinhenz; Jasleen Kukreja; Lydia Zablotska; Isabel E Allen; Kenneth Covinsky; Paul Blanc; Jonathan P Singer Journal: J Heart Lung Transplant Date: 2019-03-18 Impact factor: 10.247
Authors: Berend E Westerhof; Nabil Saouti; Willem J van der Laarse; Nico Westerhof; Anton Vonk Noordegraaf Journal: Cardiovasc Res Date: 2017-10-01 Impact factor: 10.787
Authors: Marius M Hoeper; Raymond L Benza; Paul Corris; Marc de Perrot; Elie Fadel; Anne M Keogh; Christian Kühn; Laurent Savale; Walter Klepetko Journal: Eur Respir J Date: 2019-01-24 Impact factor: 16.671
Authors: J Gleditsch; Ø Jervan; S Haukeland-Parker; M Tavoly; O Geier; R Holst; F A Klok; H H Johannessen; W Ghanima; E Hopp Journal: Int J Cardiol Heart Vasc Date: 2022-03-23
Authors: Raquel F Videira; Anne Marie C Koop; Lara Ottaviani; Ella M Poels; Jordy M M Kocken; Cristobal Dos Remedios; Pedro Mendes-Ferreira; Kees W Van De Kolk; Gideon J Du Marchie Sarvaas; André Lourenço; Aida Llucià-Valldeperas; Dian aS Nascimento; Leon J De Windt; Frances S De Man; Inês Falcão-Pires; Rolf M F Berger; Paula A da Costa Martins Journal: Cardiovasc Res Date: 2022-09-20 Impact factor: 13.081